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Abstract
Our ability to control diseases caused by parasitic nematodes is constrained by a limited portfolio of effective drugs and a
paucity of robust tools to investigate parasitic nematode biology. RNA interference (RNAi) is a reverse-genetics tool with
great potential to identify novel drug targets and interrogate parasite gene function, but present RNAi protocols for
parasitic nematodes, which remove the parasite from the host and execute RNAi in vitro, are unreliable and inconsistent. We
have established an alternative in vivo RNAi protocol targeting the filarial nematode Brugia malayi as it develops in an
intermediate host, the mosquito Aedes aegypti. Injection of worm-derived short interfering RNA (siRNA) and double
stranded RNA (dsRNA) into parasitized mosquitoes elicits suppression of B. malayi target gene transcript abundance in a
concentration-dependent fashion. The suppression of this gene, a cathepsin L-like cysteine protease (Bm-cpl-1) is specific
and profound, both injection of siRNA and dsRNA reduce transcript abundance by 83%. In vivo Bm-cpl-1 suppression results
in multiple aberrant phenotypes; worm motility is inhibited by up to 69% and parasites exhibit slow-moving, kinked and
partial-paralysis postures. Bm-cpl-1 suppression also retards worm growth by 48%. Bm-cpl-1 suppression ultimately prevents
parasite development within the mosquito and effectively abolishes transmission potential because parasites do not
migrate to the head and proboscis. Finally, Bm-cpl-1 suppression decreases parasite burden and increases mosquito
survival. This is the first demonstration of in vivo RNAi in animal parasitic nematodes and results indicate this protocol is
more effective than existing in vitro RNAi methods. The potential of this new protocol to investigate parasitic nematode
biology and to identify and validate novel anthelmintic drug targets is discussed.
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Introduction
Lymphatic filariasis is a disease caused by filarial nematodes
including Wuchereria bancrofti and Brugia malayi, transmitted through
the bite of infected mosquitoes. These parasites perpetuate
socioeconomic instability in developing countries by inflicting
crippling morbidity and debilitating stigmatization. The impact of
this disease is vast - over 120 million people are infected in 81
endemic countries [1]. In an effort to alleviate morbidity and
eliminate transmission of this disease, the Global Program for the
Elimination of Lymphatic Filariasis (GPELF) has orchestrated a
systematic mass drug administration (MDA) program centered on
the repeated dosing of either diethylcarbamazine citrate (DEC)
and albendazole or albendazole and ivermectin in areas where the
other filarial parasites, Onchocerca volvulus and Loa loa are co-
endemic. This strategy has reduced prevalence in many areas [2]
but lymphatic filariasis remains a significant global health concern.
Many factors contribute to continued transmission, but central is
the inadequate portfolio of effective drugs; none of the MDA drugs
are effective against all life stages of the parasite with notable
inefficacy against adult worms [3–5]. This means MDA must be
provided annually for the duration of the lifespan of adult
parasites. This situation is compounded by gaps in our
understanding of mechanisms of drug action and pharmacology
– the site of action of DEC is unknown despite being the drug of
choice for lymphatic filariasis control for decades, and the
filaricidal mechanism of ivermectin at therapeutic concentrations
is also equivocal. There is a very real and significant need for
additional and more effective antifilarial drugs, and a better
understanding of the mode of action of existing drugs [6].
A major obstacle to the rational development of such drugs is
the experimental intractability of parasitic nematodes. An example
of this complication is RNA interference (RNAi), a reverse genetic
tool that allows researchers to rapidly and specifically ‘turn off’
genes of interest. RNAi has fast become a standard tool in rational
drug discovery for the identification and validation of potential
new drug targets [7,8]. By suppressing specific genes and
examining the resulting phenotype, it is possible to delineate gene
function and appraise the potential value of encoded proteins as
drug targets. Successful applications of present RNAi protocols to
parasitic nematodes have been sporadically reported, limited in
their effectiveness and seldom repeated [9]. Some success has been
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Trichostrongylus colubriformis [12], Ostertagia ostertagi [13] and
Haemonchus contortus [14,15]. Germane to the study of filarial
worms, RNAi has been described in B. malayi [16,17], Onchocerca
volvulus [18,19] and Litomosoides sigmodontis [20]. The conclusion has
been reached, however, that successful RNAi ‘‘only works on a
limited number of genes, and in some cases the effect is small and
difficult to reproduce’’ [14]. The inability to depend on present
RNAi protocols with parasitic nematodes has proved a major
stumbling block to the identification and validation of new drug
targets, to a better understanding of anthelmintic mode of action,
and to advancing our comprehension of parasite biology.
The recalcitrance of animal parasitic nematodes to RNAi is
perplexing, given that Caenorhabditis elegans, a free-living nematode,
and plant parasitic nematodes are readily susceptible to the
technique [21–28]. One hypothesis advanced to explain this
recalcitrance is that because present RNAi protocols employ in vitro
approaches including soaking nematodes in an RNAi trigger,
feeding nematodes bacteria producing the trigger, or electropo-
rating of the trigger into the parasite, the RNAi trigger is not
provided in a manner conducive to systemic gene suppression
[29]. Implicit in the use of these protocols is the removal of a
parasite from the host and its maintenance in a liquid culture.
Therefore these protocols have distinct drawbacks such as
difficulty maintaining healthy, viable worms that behave normally
in vitro, limitation of use of parasites or life stages for which in vitro
culture is defined, and poor efficacy in RNAi trigger delivery
methods that can prove lethal to the parasite [30].
The aim of this study was to develop an innovative in vivo
approach to RNAi in parasitic nematodes that overcomes the
drawbacks associated with present in vitro experimental paradigms.
Our approach is based on the filarial nematode B. malayi.W e
establish a B. malayi infection in an intermediate host, the mosquito
Aedes aegypti, and then initiate suppression of parasite genes by
injecting an RNAi trigger directly into the mosquito. The
mosquito acts as an ideal culture and delivery system, ensuring
the RNAi trigger is exposed to healthy, developing parasites. Using
this approach we have effectively and quantifiably suppressed
expression of Bm-cpl-1,aB. malayi gene encoding a cathepsin L-like
cysteine protease. Dramatic aberrant phenotypes accompany this
suppression, including a marked retardation of motility, an
inhibition of normal parasite migration behavior within the
mosquito and impaired parasite growth and development.
Suppression is specific; non-target RNAi has no effect on
nematode viability or behavior, and the level of gene suppression
and extent of the resultant phenotypes suggest this new protocol is
more effective than previous methods. The development of an in
vivo RNAi protocol to reliably suppress gene expression in filarial
worms has great potential for the identification and validation of
novel drug targets, and more broadly, to explore parasitic
nematode biology and host-parasite interactions.
Results
A Brugia RNAi trigger rapidly disseminates throughout
the mosquito host
Our hypothesis is that mosquitoes provide an optimal culture
and delivery system for an RNAi trigger targeted to developing
Brugia malayi parasites. Healthy, viable, developing parasites are
subjected to the RNAi trigger because the parasites undergo
growth and development in the mosquito intermediate host. In
order to test the extent of dissemination of the RNAi trigger from
the site of intrathoracic injection, 150 ng of an equimolar mix of
four 39 Cy 3-labelled Bm-cpl-1 siRNAs was injected into adult Aedes
aegypti mosquitoes as described. The dissemination of this RNAi
trigger through the mosquito was tracked over 15 d post-injection
by periodic microdissection of the mosquito and evaluation of
internal fluorescence compared to saline injected controls. The
labeled siRNA mix spread rapidly from the site of injection and
maximal fluorescence was observed 24 h post-injection (Fig. 1).
The intensity of fluorescence slowly decreased until reaching basal
levels at five d post-injection after which fluorescence intensity was
not appreciably different from control mosquitoes. Our observa-
tions closely parallel those of a previous report that describes the
spread of 140 ng AlexaFluor 555-labeled siRNA in the mosquito
Anopheles gambiae from an injection site to the midgut and
pericardial cells 36 h post-injection [31]. Systemic dispersion and
persistence of RNAi signal from the site of injection suggests B.
malayi larvae are likely to be exposed to the RNAi trigger in our
experimental model.
Brugia gene suppression in vivo is potent and specific
Recently it has been shown that B. malayi genes encoding
cathepsin L-like enzymes can be suppressed in vitro by soaking
adult parasites in culture media containing siRNA [17]. We tested
the capacity of our novel methodology to suppress larval stage B.
malayi gene expression in vivo by injecting mixed siRNAs specific to
the cathepsin L-like Bm-cpl-1 gene directly into Ae. aegypti
mosquitoes harboring L3 stage B. malayi parasites. Gene
suppression was assayed 48 h post-injection using a semi-
quantitative RT-PCR in which the intensity of Bm-cpl-1
amplification in the linear phase of the reaction was compared
to an internal B. malayi reference gene (Bm-flp-14) that is expressed
stably and at comparable levels to Bm-cpl-1. Control mosquitoes
were injected with equal volumes of Aedes physiologic saline. This
methodology was optimized to amplify Bm-cpl-1 from a heteroge-
neous mosquito/parasite total RNA preparation from a single
mosquito. Suppression was concentration-dependent because
injection of 0.15 ng siRNA did not appear to reduce Bm-cpl-1
transcript levels. However, injection of 15 ng or 1.5 ng of siRNA
decreased transcript levels, and injection of 150 ng mixed siRNA
into mosquitoes profoundly suppressed Bm-cpl-1 expression; the
Author Summary
Lymphatic filariasis is a debilitating tropical disease caused
by parasitic nematodes such as Brugia malayi that are
transmitted to humans through the bite of infected
mosquitoes. Controlling lymphatic filariasis, and other
parasitic nematode diseases, is made difficult by a limited
repertoire of sub-optimal drugs and substantial experi-
mental roadblocks to new drug development. We have
developed a novel and highly effective in vivo RNA
interference (RNAi) methodology to better understand
gene function in the parasitic nematode, B. malayi. RNAi
triggers are delivered to developing parasites in the
mosquito intermediate host – an improvement on existing
RNAi protocols, in which the parasite is removed from the
host and maintained in liquid culture. Using this protocol
we have significantly suppressed a cathepsin gene in B.
malayi, which resulted in dramatic change to parasite
movement, growth and development in the mosquito to
the extent that worms cannot be transmitted to a new
host. These data underscore the power of this protocol to
1) critically assess gene function in parasitic nematode
biology, 2) to reveal the mechanism of action for existing
drugs, and 3) for discovery of novel drug targets for drug
development.
In Vivo RNAi in Brugia malayi
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suppression was also specific; expression of the Bm-flp-14 reference
gene was unaffected by siRNA injection and target gene
expression was normal in saline-injected controls.
Application of dsRNA is the commonly used method for
triggering RNAi in parasitic nematodes and has advantages over
siRNA; dsRNA can be generated in-house more quickly than
commercially produced siRNAs at lower cost. B. malayi-infected
mosquitoes were also subjected to treatment with dsRNA as an
RNAi trigger. The effect of dsRNA was concentration-dependent
such that injection of 15 ng dsRNA results in Bm-cpl-1 suppression
but 1.5 ng dsRNA had no appreciable effect. Injection of 150 ng
of dsRNA potently suppressed Bm-cpl-1 transcript abundance and
suppression appeared specific, with Bm-flp-14 expression unaffect-
ed by dsRNA (Fig. 2).
RT-qPCR was used to quantify the level of Bm-cpl-1 suppression
relative to two reference genes (Bm-flp-14 and Bm-tph-1) using the
efficiency-corrected (E
DDCq) relative quantification method [32].
PREXCEL-Q software was used to optimize the performance of
the RT-qPCR assay; and important data pertinent to PCR
efficiency, linear dynamic range and normalization of the assay are
documented in Table 1. Bm-tph-1 showed stable Cq values across
the experiment and therefore was the most appropriate reference
gene for these studies, as shown previously [33]. The suppressive
effects of both RNAi treatments were almost identical; injection of
150 ng siRNA reduced Bm-cpl-1 transcript by 83% compared to
saline-injected controls (P,0.0001) and 150 ng dsRNA also
reduced Bm-cpl-1 transcript by 83% (P,0.0001) (Fig. 3). Bm-flp-
14 reference gene transcript was slightly reduced by both RNAi
treatments but these reductions were not significant (siRNA, 9%,
P = 0.38; dsRNA, 12%, P = 0.17). These data support the gel-
based semi-quantitative RT-PCR experimental findings and
demonstrate the efficacy of this novel method of RNAi delivery.
Bm-cpl-1 suppression elicits marked motility and
developmental phenotypes
Previous studies have described aberrant filarial worm pheno-
types associated with cathepsin L-like gene suppression in vitro
including decreased microfilariae (mf) release from adult B. malayi
[17] and an inhibition of the L3 to L4 molt in Onchocerca volvulus
[18]. Based on these data, we predicted that Bm-cpl-1 suppression
would produce a phenotype in vivo in the mosquito host.
Mosquitoes were injected with 150 ng Bm-cpl-1 dsRNA 10 d
post-infection (dpi) then microdissected four d post-injection to
harvest L3-stage parasites. Worm motility was digitally recorded
and scored according to a five-point schema of one (immobile), to
five (all parts of the worm in constant motion). 100% of control
worms from mosquitoes injected with Aedes physiologic saline were
categorized as four or five on this scale. Bm-cpl-1 suppression
significantly inhibited this normal worm motility (P,0.001), with
only 67% of worms ranked as four or five on the scale (Fig. 4). To
confirm that this effect was Bm-cpl-1 specific and not due to
exogenous dsRNA impairing worm viability, this experiment was
repeated with dsRNA for enhanced GFP (eGFP) as a random
exogenous RNA. These worms were phenotypically identical to
saline-injected controls (100% category four or five), confirming
the specificity of the aberrant phenotype in Bm-cpl-1 suppressed
worms.
The effect of changing the timing of Bm-cpl-1 suppression on
worm motility was also examined. Bm-cpl-1 transcript levels are
elevated in L3 stage parasites, such that this gene has a purported
role in the L3 to L4 molt [18]. The temporal expression of Bm-cpl-
1 was reported to be up-regulated during the L2 to L3 transition,
at six to seven dpi [34]. Based on the timing of Brugia development
in Ae. aegypti [35], infected mosquitoes were injected with Bm-cpl-1
dsRNA at 10 dpi in order to target L3-stage worms (described
above) and at seven dpi to target the L2 to L3 transition. Parasites
exposed to Bm-cpl-1 dsRNA at seven dpi showed significantly
inhibited motility compared to saline controls (P,0.001) with only
31% of worms displaying normal motility. The difference between
parasites exposed to dsRNA at seven and 10 dpi was significant
(P,0.001), and may reflect an important biological role for Bm-cpl-
1 during the transition from L2 to L3 stages. More explicitly,
earlier exposure to the RNAi trigger could impose more significant
detrimental impact on the parasite by disrupting the L2 to L3
molt, or it may simply be a consequence of the longer period of
time from gene suppression to phenotype assay, allowing Bm-
CPL-1 rundown and maturation of the phenotype.
Figure 1. Dissemination and persistence of intrathoracically injected Cy 3-labelled Brugia malayi Cathepsin-L1 siRNAs in Aedes
aegypti. Midgut and Malpighian tubule tissues are shown in light (upper panel) and fluorescence (lower panel) micrographs from 1 to 9 days post-
injection (scale bar 100 mm).
doi:10.1371/journal.ppat.1001239.g001
Figure 2. Concentration-dependent, in vivo suppression of
Brugia malayi Cathepsin-L1 (Bm-cpl-1) using siRNA (Top) or
dsRNA (Bottom) RNAi triggers. Micrograph shows ethidium
bromide stained agarose gel electrophoresis of relative RT-PCR analysis
of individual, B. malayi-infected mosquitoes 48 h post-injection of RNAi
trigger at 10 d post-infection. Amplified product for the target gene,
Bm-cpl-1, is shown above a neuropeptide reference gene (Bm-flp-14).
doi:10.1371/journal.ppat.1001239.g002
In Vivo RNAi in Brugia malayi
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motility phenotypes were apparent in Bm-cpl-1 suppressed worms.
A highly active, convoluted body form characterizes motility of
healthy B. malayi L3s, both the heads and tails of the parasites in
particular are conspicuously tortuous – curvature we described as
‘knotted’. Control worms from saline-injected mosquitoes fre-
quently (86% of worms) displayed knotting at both ends.
Suppression of Bm-cpl-1 10 dpi significantly inhibited this motility,
because only 14% of worms presented with both ends knotted
(P,0.001) (Fig. 5). This phenotype was enhanced by an early
suppression of Bm-cpl-1 at seven dpi such that no Bm-cpl-1
suppressed parasites exhibited this knotting morphology. The
difference between L2 and L3 Bm-cpl-1 suppression was significant
(P = 0.005). Worms exposed to the exogenous eGFP dsRNA
control confirmed that this phenotype was gene-specific because
parasite motility was not significantly different from saline controls
(85% knotted at both ends, P = 0.2). Another aberrant motility
observed was the presence of a perturbed section of body wall
slightly caudal to the midpoint of the worm. This abnormal kinked
morphology was absent from control worms (4% of worms from
saline-injected and 0% from eGFP-injected mosquitoes displayed
this morphology), but evident with significantly greater frequency
in 10 dpi Bm-cpl-1 suppressed worms (47%, P,0.001) (Fig. 6). This
kink rate increased with Bm-cpl-1 suppression at seven dpi (63%),
but compared to 10 dpi this was not significant (P = 0.08). Finally,
partial paralysis of Bm-cpl-1 suppressed worms was evident,
presenting as immobility in the caudal third of the worm. This
paralysis was observed in 61% of 10 dpi Bm-cpl-1 suppressed
worms, and 83% of seven dpi suppressed worms (this increase was
significant, P = 0.005) but was generally absent from control
worms (5% of worms from saline-injected mosquitoes and 3% of
worms from eGFP-injected mosquitoes) (Fig. 6).
To examine the consequence of this aberrant motility on B.
malayi development, mosquitoes were injected with 150 ng Bm-cpl-
1 dsRNA 10 dpi then microdissected four d post-injection,
partitioning the mosquitoes into head, thorax and abdomen
preparations. Control worms from mosquitoes injected with either
saline or eGFP dsRNA were found exclusively (100%) in head
preparations as expected. Bm-cpl-1 suppressed worms were most
frequently observed escaping from the thorax and abdomen
(Fig. 7). Parasites in Bm-cpl-1 dsRNA-injected mosquitoes,
however, did not leave the thorax (94% of worms were found
here) or abdomen (6%). Bm-cpl-1 suppression, therefore, prevents
worm migration to the head of the mosquito, effectively preventing
Table 1. Reportable information on RT-qPCR experiment.
Bm-cpl-1 Bm-flp-14 Bm-tph-1
siRNA dsRNA siRNA dsRNA siRNA dsRNA
RT-qPCR efficiency (%) 84.7 65 108.2 116.5 104.2 96.4
Calibration curve y intercept 30.6 32.9 33.9 35.9 29.5 33
Calibration curve r
2 0.98 0.97 0.91 0.88 0.99 0.88
Mean Cq 30.460.06 33.060.48 34.360.13 35.760.19 30.060.08 33.160.10
NTC Cq 50 50 50 50 50 50
doi:10.1371/journal.ppat.1001239.t001
Figure 4. Aberrant motility of dsRNA Bm-cpl-1-exposed B.
malayi. Frequency distribution for motility of L3 stage B. malayi
recovered from Ae. aegypti showing significantly reduced motility of
Bm-cpl-1 suppressed worms. Parasitized mosquitoes were injected with
saline (control), 150 ng eGFP dsRNA, or 150 ng Bm-cpl-1 dsRNA at 7 or
10 d post-infection (dpi), then dissected to obtain parasites at 14 dpi.
Parasite motility was scored on a 1–5 scale, with 1= immobile and 5=
all parts of worm in constant motion (control n=101, dseGFP n=68,
dsBm-cpl-1 10 dpi n=70, dsBm-cpl-1 7 dpi n=48, P,0.001).
doi:10.1371/journal.ppat.1001239.g004
Figure 3. Quantitative PCR demonstrates significant reduction
in Bm-cpl-1 transcript levels as a result of siRNA and dsRNA
RNAi trigger injection into B. malayi-infected Ae. aegypti. Both
siRNA (A) and dsRNA (B) injection reduces Bm-cpl-1 transcript by 83%
compared to controls (saline injected Ae. aegypti infected with B.
malayi). Bm-cpl-1 and control gene, Bm-flp-14, are normalized to a
reference gene Bm-thp-1. qPCR was performed 48 h post-injection of
RNAi trigger at 10 d post-infection. Each bar represents 13 mosquitoes
from three biological replicates.
doi:10.1371/journal.ppat.1001239.g003
In Vivo RNAi in Brugia malayi
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the potential for parasite transmission.
A significant negative effect also was seen on growth and
development of parasites subjected to Bm-cpl-1 suppression.
Parasitized mosquitoes were injected with 150 ng Bm-cpl-1 dsRNA
seven dpi then microdissected 14 dpi and the length, width and
appearance of the worms recorded. Mosquitoes were injected
seven dpi because the previous motility experiments dictated that
this experimental timing generated the most pronounced motility
phenotypes. Bm-cpl-1 suppression significantly reduced the length
of L3 worms by 48% (P,0.0001)(Fig. 8). The mean length of
control L3, removed from mosquitoes seven d after saline injection
and 14 dpi, was 1347618 mm. This was reduced to 700649 mm
after RNAi treatment. Unlike parasite length, width was not
significantly affected by Bm-cpl-1 suppression, although a slight
decrease of 5% was observed (P = 0.39) from 3161 mm in control
worms to 3062 mm in RNAi worms. In addition to worm length,
the majority of Bm-cpl-1 dsRNA parasites also presented with
additional aberrant developmental phenotypes. Most evident was
a disruption of the cuticle (Fig. 8B), which extended significantly
beyond the body of the worm. Some degree of this cuticular
sloughing was noticed in most worms but the severity of this
phenotype was variable. Finally, the integrity of the gut appeared
compromised in Bm-cpl-1 worms. In such instances, the gastroin-
testinal tract of the parasites appeared incomplete and porous
when examined at the light microscope level.
Bm-cpl-1 suppression enhances mosquito survival and
decreases parasite prevalence
Phenotype data resoundingly demonstrate that Bm-cpl-1 sup-
pression decreases B. malayi viability. It is logical to predict that this
Figure 5. Disrupted motile phenotypes of dsRNA Bm-cpl-1-
exposed B. malayi. Frequency distribution for parasites exhibiting
rigorous knotting behavior at both ends of worm, one end, or not at all
showing normal terminal curvature is inhibited by Bm-cpl-1 suppres-
sion. Parasitized mosquitoes were injected with saline (control), 150 ng
eGFP dsRNA, or 150 ng Bm-cpl-1 dsRNA at 7 or 10 d post-infection (dpi),
then dissected to obtain parasites at 14 dpi (control n=101, dseGFP
n=68, dsBm-cpl-1 10 dpi n=70, dsBm-cpl-1 7 dpi n=48).
doi:10.1371/journal.ppat.1001239.g005
Figure 6. The frequency of caudal paralysis and kinked posture
of dsRNA Bm-cpl-1-exposed B. malayi. The frequency of both caudal
paralysis and kinked posture is significantly increased with Bm-cpl-1
suppression. Parasitized mosquitoes were injected with saline (control),
150 ng eGFP dsRNA, or 150 ng Bm-cpl-1 dsRNA at 7 or 10 d post-
infection (dpi), then dissected to obtain parasites at 14 dpi (control
n=101, dseGFP n=68, dsBm-cpl-1 10 dpi n=70, dsBm-cpl-1 7 dpi
n=48, P,0.001).
doi:10.1371/journal.ppat.1001239.g006
Figure 7. dsRNA Bm-cpl-1-exposed B. malayi fail to migrate to
the head of the mosquito. Frequency distribution of infectious (L3)
stage B. malayi recovered from Ae. aegypti in the head, thorax or
abdomen of the mosquito host. Parasites were dissected from Ae.
aegypti mosquitoes 14 d post-infection and 4 d post-injection of saline
(control), 150 ng eGFP dsRNA or 150 ng Bm-cpl-1 dsRNA. One worm
was recovered from each mosquito. Numbers of mosquitoes dissected
from three biological replicates: n=18 (control), n=20 (dseGFP), and
n=31 (dsBm-cpl-1).
doi:10.1371/journal.ppat.1001239.g007
Figure 8. Bm-cpl-1-suppressed B. malayi are significantly shorter
than control worms. Parasites were dissected from Ae. aegypti
mosquitoes 14 days post-infection and 4 d post-injection of saline
(control, A) or 150 ng Bm-cpl-1 dsRNA (B). Scale bar 250 mm. (C) RNAi-
exposed parasites are significantly shorter in length, but not width, than
control worms. Numbers of parasites from three biological replicates:
n=19 (control) and n=13 (dsBm-cpl-1) (P,0.001).
doi:10.1371/journal.ppat.1001239.g008
In Vivo RNAi in Brugia malayi
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survival and prevalence of parasite infection. To examine this,
mosquitoes were injected with 150 ng Bm-cpl-1 dsRNA 10 dpi and
the number of mosquitoes that survived through the development
of parasites to the infectious stage, 14 dpi, was counted. Surviving
mosquitoes then were microdissected to determine the proportion
that harbored parasite infections. Bm-cpl-1 suppression increases
host mosquito survival. The survival rate of control mosquitoes
injected with saline or eGFP dsRNA was 62% and 65%
respectively (P = 0.6) as compared to 80% in Bm-cpl-1 RNAi-
exposed mosquitoes (P,0.001) (Fig. 9A). Early suppression of Bm-
cpl-1 at seven dpi enhanced the phenotype even more significantly
such that 93% of mosquitoes were alive at the termination of the
experiment (P = 0.007). This increased mosquito survival rate
after Bm-cpl-1 suppression may be as a result of the parasite’s
compromised ability to feed on, and migrate through, the host or
may result from a more successful or effective host response
against parasites with decreased viability. This hypothesis is
supported by our observation that Bm-cpl-1 suppression also
decreased prevalence of infection – fewer surviving mosquitoes
harbored parasites after Bm-cpl-1 RNAi (Fig. 9B). Every surviving
mosquito injected with saline or eGFP was found to contain
parasites 14 dpi, but 14 dpi Bm-cpl-1 suppressed parasites (exposed
to dsRNA at 10 dpi) were found in just 76% of mosquitoes, a
significant reduction in prevalence (P,0.001). Prevalence was
further reduced to 62% in parasites exposed to Bm-cpl-1 dsRNA at
seven dpi, a statistically significant decrease compared to worms
exposed to the dsRNA trigger at 10 dpi (P = 0.03).
Discussion
Here we report the development of a novel in vivo approach to
RNAi in the filarial nematode Brugia malayi, and describe its
application first to suppress the expression of Bm-cpl-1,aB. malayi
gene encoding a cathepsin L-like cysteine protease, then to
validate this gene as a potentially potent anthelmintic drug target.
To the best of our knowledge, this is the first description of in vivo
RNAi in parasitic nematodes and represents an advance in the
study of filarial nematode biology that may aid in the development
of drugs to combat parasitic nematode infection. The rationale for
developing an in vivo RNAi protocol stems from the hypothesis that
RNAi is ineffective in animal parasitic nematodes because the
supply of an RNAi trigger to the worms is inappropriate [29]. Our
overarching hypothesis was that RNAi would work effectively and
robustly if a trigger is supplied to healthy, viable worms in a host
environment. Supporting this hypothesis, we were able to
specifically reduce target gene transcript abundance in B. malayi
larvae by 83% by supplying an RNAi trigger to parasites
developing within the mosquito host. This level of transcript
knockdown has not previously been reported using current in vitro
RNAi soaking methods. The ‘in squito’ approach to RNAi we
describe is effective for the specific suppression of cathepsin genes
in Brugia larval stages as they develop within their cognate
mosquito host; it is therefore possible that this in vivo approach may
represent a more effective means of eliciting gene suppression in
filarial nematodes.
The mechanism by which the RNAi trigger is delivered to the
parasites ‘in squito’ is unclear, but could be a result of bathing the
parasite in the trigger within a cell, or as a result of uptake by tissue
ingestion. In support of the former, Cy3-labeled siRNA injected
into the haemocoel rapidly disseminates throughout the mosquito
supporting a hypothesis that the developing parasites are
effectively incubating in a host milieu containing an RNAi trigger,
essentially a scenario analogous to in vitro RNAi by soaking. If this
is the case, the ‘in squito’ approach represents an efficient way to
generate gene suppression by soaking. Most successful animal
parasitic nematode in vitro soaking protocols use large amounts of
ds- or siRNA with concentrations of 1 mg/ml typical, meaning
anywhere between 25 mg and 2 mg of RNAi trigger are required
per suppression experiment [10–19], with the exception of one
report showing that lower trigger concentrations could still be
effective at producing gene suppression by soaking [20]. Here we
showed that gene suppression can be achieved using just 150 ng of
ds- or siRNA per RNAi event, and indeed, a reduction in
transcript abundance was observed after injecting as little as 15 ng
dsRNA. In addition to the obvious cost saving advantages to
performing RNAi experiments in this manner, such low RNA
concentrations may also improve the specificity of gene suppres-
sion. Soaking plant parasitic nematodes in serial dilutions of ds-
and siRNAs has been shown to reduce off-target effects in RNAi
experiments [28,36]. A second delivery hypothesis is that the
developing parasites are ingesting the RNAi trigger. Microfilariae
Figure 9. Ae. aegypti survival significantly increases as infection
prevalence decreases in Bm-cpl-1-dsRNA exposed mosquitoes.
The effects on survival (A) and infection prevalence (B) are most
profound in parasites exposed to Bm-cpl-1 dsRNA at the L2/L3 transition
(7 d post-infection, dpi). Parasites were exposed to saline (control),
150 ng eGFP dsRNA or 150 ng Bm-cpl-1 dsRNA at 7 or 10 dpi, then were
dissected from Ae. aegypti mosquitoes at 14 dpi.
doi:10.1371/journal.ppat.1001239.g009
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midgut [37], and migrate to the thoracic musculature where they
grow and develop to the L3 stage [38,39], a process completed in
under two weeks [35]. From the L2 stage, the developing larvae
are active feeders and consume host tissue [35,40,41], a behavior
that would lead to the ingestion of an injected RNAi trigger in our
experimental model. RNAi by feeding is a well-established method
in free-living nematodes [22,23,42,43]; by feeding these worms
bacteria expressing dsRNA, systemic gene suppression can be
effected in a relatively simple and efficient manner. This approach
has not been successful with parasitic nematodes, however, as most
parasitic species are not bacteriotrophic, and even for those species
with bacteriotrophic life stages, this method is unreliable [30].
Resolution of the RNAi trigger delivery mechanism afforded by
our in vivo protocol may come through targeting B. malayi L1
worms in the mosquito. If target gene expression can be reduced in
this non-feeding stage, this would support soaking as the prime
mechanism.
The in squito suppression of Bm-cpl-1 reveals new phenotypes
associated with molting, growth and development, and motility
that shed light on the important biological functions of this gene
family in larval stages of B. malayi. Nematode molting is a three-
stage process characterized by a shedding or separation of the old
cuticle from the epidermis (apolysis), generation of a new cuticle,
then the shedding of the old cuticle (ecdysis). The use of specific
cysteine protease inhibitors markedly inhibits the L3 to L4 molt in
filarial worms implicating cysteine proteases in general in this
process [34,44,45]. More explicitly, both apolysis and ecdysis are
disrupted giving rise to L4 parasites constrained within an L3
cuticle, termed an ‘accordion’ phenotype [34]. Multiple members
of the cathepsin L-like family appear to be involved in molting as
the specific suppression of cpl-1 alone in Onchocerca vovlvulus reduced
but did not abrogate the L3 to L4 molt [18]. We show that Bm-cpl-
1 is also involved in similar processes in B. malayi as its suppression
manifested an aberrant cuticular phenotype in L3 worms.
Examination of worms suppressed at seven dpi revealed an
apparent sloughing of the cuticle without the accordion pheno-
type. As the L3 to L4 molt occurs in the vertebrate host this
phenotype is not a disruption of the L3 to L4 molt, but rather a
dysfunction in L3 cuticle formation, maintenance or development.
Alternatively, we could be observing a disruption of the L2 to L3
molt. Bm-cpl-1 expression is up-regulated in the L3 stage but the
exact timing of this up-regulation as it relates to the transition from
L2 to L3 stages is unclear. Guiliano et al. [34] report Bm-cpl-1 up-
regulation at six dpi, a window consistent with the L2 to L3
transition. If Bm-cpl-1 performs the same function for the L2 to L3
molt as for the L3 to L4 molt, then the sloughed cuticle we observe
upon dsRNA injection at seven dpi could be that of the L2, with
Bm-cpl-1 suppression preventing ecdysis. Further examination of
cuticle ultrastructure in these suppressed worms at the electron
microscope level could provide evidence to this effect.
We observed a stunting of Bm-cpl-1 suppressed L3 growth
compared to control worms, a phenotype previously unreported
either after chemical inhibition of cysteine proteases or gene
suppression in other parasite stages. Normally at the end of the L2
stage parasites are 750–795 mm long and increase in length to
approximately 1350 mm at the L3 stage within four d [38]. Our
control L3, taken from mosquitoes injected with saline, had a
mean length of 1347 mm corresponding closely with the published
data. The mean length of Bm-cpl-1 suppressed L3, however, was
significantly shorter (700 mm). Suppression of this gene at the L2/
L3 interface (seven dpi) arrests parasite growth and the L3 worms
remain L2-sized within the mosquito. One explanation for this
observation is that Bm-cpl-1 suppression at the L2/L3 interface is
inhibiting the L2 to L3 molt, L2 cuticle ecdysis is not successful
and therefore the worms are constrained within it, unable to
increase their length. Alternatively, the stunting may not be due to
aberrant molting but rather an inhibition of normal CPL-
regulated development or cellular remodeling post-molt as is seen
in other nematodes [46]. RNAi suppression of cpl-1 in C. elegans L3
by soaking produced significantly shorter and thinner adults [46]
and the localization of cpl-1 to the hypodermis in C. elegans, O.
volvulus and B. malayi is consistent with a developmental role in
nematodes [18,34,46]. Further, germline suppression of cpl-1 in C.
elegans by dsRNA injection generated an embryonic lethal
phenotype but some embryos did progress to the L1 stage and
those had incomplete gut development [46]. A repeatedly
observed phenotype in our Bm-cpl-1 suppressed L3 was a
compromised gut that appeared fenestrated and poorly developed.
Finally, Bm-cpl-1 suppression reduced normal L3 motility by up
to 69%, increased atypical postural phenotypes including caudal
paralysis, kinked appearance and reduced normal convolution at
the head and tail of B. malayi L3 as compared to control worms.
These behaviors made it impossible for the treated L3 to progress
through to the culmination of development in the mosquito host,
i.e., transfer to the definitive host. The dystaxic behaviors
produced by the suppression of Bm-cpl-1 suggest this gene has
some role, directly or indirectly, in the neuromuscular activity of B.
malayi L3 in the mosquito. It is certainly true that cathepsins are
required for normal neuromuscular behavior in other helminths;
suppression of a cathepsin L-like gene in the flatworm Fasciola
hepatica generated several aberrant motile phenotypes including
paralysis [47].
This study is the first to use the host as a delivery mechanism for
animal parasitic nematode RNAi. The model of using the host as a
delivery mechanism for RNAi has been established but has been
restricted to plant pathology where the concept has an applied use
with transgenic plants helping to control nematode infestation by
RNAi mechanisms in planta [48–50]. An alluring corollary is that
by generating transgenic mosquitoes capable of suppressing key
nematode genes in vivo we may be able to abolish parasite
transmission. We have already demonstrated here that Bm-cpl-1
suppression in vivo prevents parasites migrating to the mosquito
head and proboscis thus eliminating transmission potential.
Transformation of a mosquito with an inverted-repeat (IR)
transgene derived from Bm-cpl-1 may result in endogenous
transcription of a hairpin dsRNA, a trigger that conceptually
would induce RNAi in vivo as described here and produce a
mosquito incapable of transmitting lymphatic filariasis-causing
worms. Methods to introduce transgenes into mosquito germlines
are well established [51–55] and proof of this principle has already
been demonstrated for a mosquito-borne virus; transgenic lines of
Dengue virus-resistant mosquitoes were generated using a Dengue
virus IR transgene driven by the carboxypeptidase A promoter,
reducing virus transmission by an RNAi mechanism [56]. The
viability of this approach is enhanced not only by the ability to
transform important vector species but also by the identification of
tissue-specific promoters to drive transgene expression in favorable
tissues, for example, act88F [57] is a fly-specific promoter that
drives gene expression in the flight musculature – the precise site of
parasite development. Another positive impact this protocol may
have on lymphatic filariasis control is as a means of better
understanding the biology of current putative drug targets and
generating new data that may validate proposed novel drug
targets. This protocol introduces the ability to investigate
mosquito-borne parasite life stages, allowing the critical examina-
tion of gene function in worms growing and developing in an
optimum environment. This makes it possible to assay genes that
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native intermediate host, contextualizing the null phenotypes in
vivo and accurately determining the consequences of target gene
suppression producing a more valuable target validation. As an
illustration, nematode cathepsins have been proposed as attractive
novel drug targets [58] and we have further validated these drug
targets in vivo, revealing new phenotypes, defining new biological
roles and showing that B. malayi sans Bm-cpl-1 are incapable of
completing their life cycle. These data enhance the appeal of
cathepsins as novel anthelmintic drug targets. Beyond cathepsins,
this technique will have most utility in the investigation of known
and potential antifilarial drug target genes expressed in both the
mosquito-borne life stages and those life stages that are vulnerable
to chemotherapeutic intervention.
In summary, we have developed an innovative RNAi protocol
using B. malayi that differs conceptually from present RNAi
protocols in that parasite gene expression is suppressed within the
mosquito intermediate host. Using this protocol we suppressed a B.
malayi gene in vivo, eliciting aberrant developmental and motility
phenotypes in the parasite – phenotypes that eliminate transmis-
sion potential. In contrast to present RNAi methods, we have
found the protocol to be reliable and effective, providing a major
advancement in our capability to better understand filarial
nematode gene function to the benefit of human health.
Materials and Methods
Mosquito maintenance and injection protocol
Aedes aegypti (Liverpool strain), previously selected for suscepti-
bility to filarial parasites [59], were maintained in a contained
environment at a constant temperature of 25uC, 80% relative
humidity and a 14 h light to 10 h dark photoperiod. The
mosquitoes were fed a diet of 0.3 M sucrose. Throughout the
study mosquitoes to be injected were anaesthetized on ice and
immobilized on a vacuum saddle before being microinjected
intrathoracically at the base of the head using a pulled borosilicate
glass pipette attached to a manual syringe for injection by volume
displacement. A maximum volume of 0.5 mL can be injected using
this approach with a high mosquito survival rate (.95%).
Establishing Brugia infection
B. malayi microfilaria (mf) infected cat blood was obtained from
the University of Georgia NIH/NIAID Filariasis Research
Reagent Resource Center. To establish a consistent and
repeatable parasitemia, mf were first purified using a filtration
protocol [60]. Blood containing the parasites was diluted with
phosphate buffered saline (1:5 ratio, blood:PBS) then syringe
filtered through a 0.45 mm Millipore filter. Captured mf were
washed three to five times with PBS then a further three to five
times with Aedes physiologic saline [61] before centrifugation at
6,8006g for five min. Supernatant was removed and the pelleted
mf resuspended in fresh Aedes saline to a concentration of 40
worms per mL. To inoculate mosquitoes, 20 mf were injected as
described. Microdissection of the mosquitoes throughout a 14 dpi
period confirmed this method established a controlled infection
that progressed in a predictable and consistent manner. We also
tried a blood feeding approach to establish infection but this
produced an inconsistent worm burden that is too variable to
reliably assess subsequent gene suppression experiments.
siRNA and dsRNA generation and injection
Short interfering RNAs (siRNA) targeting a B. malayi cathepsin
L-like gene (Bm-cpl-1 AF331035 [34]) were generated commer-
cially (Qiagen, CA) and modified with a 39-Cy3 fluorophore on
the sense strand. The location of each siRNA was optimized using
a proprietary algorithm and the sequence of each siRNA is as
follows: BmCL1-1, AAGGCTTAGTTTCTTATACAA; BmCL1-
2, CCGAATGGAAAGATTATGTAA; BmCL1-3, CAGAA-
GTGCATTGAAGGAATA; and BmCL1-4, CCGGTATTT-
ACTCCAGTAATA. Equimolar amounts of each siRNA were
combined and this mix was used for injection and gene
suppression experiments. dsRNA duplexes were generated in-
house using a T7 transcription-based approach. A 410 base pair
transcription template was polymerase chain reaction (PCR)
amplified from a B. malayi L3 stage cDNA library (kindly provided
by Dr. S. Williams, Smith College, MA) using gene specific
oligonucleotides designed to incorporate a T7 promoter sequence
(TAATACGACTCACTATAGGGTACT) at both the 59 and 39
ends of the amplicon. For the Bm-cpl-1 template, oligonucleotide
sequence was: L1T7dsRNAF 59 TAATACGACTCACTA-
TAGGGTACTACGGTTACCAAATTC 39 and L1T7dsRNAR
59 TAATACGACTCACTATAGGGTACTCGACAACAACA-
GGTC 39. The location of this transcription template was
carefully chosen so as to exclude the pro region of Bm-cpl-1,a
domain with high sequence homology to other cathepsin L family
genes, and consequently increase the specificity of this dsRNA
duplex. Transcription templates were gel purified and dsRNA
duplexes synthesized using the MEGAscript RNAi Kit (Ambion,
TX) according to manufacturer’s protocols. dsRNA species were
quantified with a NanoVue spectrophotometer (GE Healthcare,
NJ) prior to use. The timing of siRNA or dsRNA injection into B.
malayi-infected mosquitoes coincided with the presence of the
parasite stage of interest: to target second larval stage (L2) parasites
siRNA or dsRNA were injected five to eight dpi; to target third
larval stage (L3) parasites siRNA or dsRNA were injected nine to
12 dpi (and for the lifespan of mosquito) [35]. The mosquitoes
were processed to confirm suppression of the target gene, as
described below, 48 h post-injection of siRNA or dsRNA.
Relative quantitative RT-PCR
Brugia infected, RNA-treated and control mosquitoes were cold-
anesthetized on ice. Total RNA was extracted from individual
mosquitoes using RNAqueous Kit (Ambion, TX) before DNase
treatment using the TURBO DNA-free Kit (Ambion, TX) in thin-
walled PCR tubes. The RNA was stabilized with RNase Out
Inhibitor (Invitrogen,CA)andstoredinRNase-free microcentrifuge
tubes at 4uC. This RNA was used as a template for a relative semi-
quantitative multiplex RT-PCR using the SuperScript III One-Step
RT-PCR System with Platinum Taq DNA Polymerase (Invitrogen,
CA). The principle of this reaction is to amplify a target gene of
interest and compare its intensity with a multiplexed and
normalized internal standard during the linear phase of product
amplification. A putative neuropeptide encoding gene, Bm-flp-14
(Accession number AI508026) served this role. This gene was
chosen as we had previously determined its stable transcript
production during the B. malayi L3 stage by PCR (C. Song,
unpublished). The oligonucleotide primers used to amplify Bm-cpl-1
were: CPL-1 F 59 ACAGGGCAATATGACGAGAC 39 and CPL-
1R5 9 ATCGAAGCAACGTGGCACAT 39. These primer
locations flank the region of Bm-cpl-1 homologous to the dsRNA
construct. The oligonucleotide primers used to amplify the Bm-flp-
14 internal standard were: FLP-14 F 59 CTCGT-
CCACTCTTATCACTG 39 and FLP-14 R 59 ACCGCAATGA-
TATACAACATATA 39. The profile for this PCR was: cDNA
synthesis at 50uC for 30 minutes; an initial denaturation phase of
94uC for 2 min; 38 cycles of 94uC for 30 s, 60uC for 30 s, 68uC for
1 min and a final extension phase of 68uC for 5 min. Reactions
werevisualized ona1.2%agarosegelcontainingethidiumbromide.
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Total RNA was extracted from individual mosquitoes and
DNase-treated as described above for three replicated RNAi
experiments and before addition of RNase Out Inhibitor and
storage, each RNA sample was quantified spectrophometrically
per a previous report [62]. This RNA served as a template in our
RT-qPCR assays using the qScript One-Step Fast RT-PCR Kit
with ROX (Quanta BioSciences, MD).
Establishing PREXCEL-Q parameters. PREXCEL-Q, a
qPCR assay development and project management software, was
used to establish our RT-qPCR parameters and to determine valid
working ranges for all of our samples per target and reference
genes. A mixture of the RNA samples was used to determine the
optimum template to use while avoiding RT-qPCR inhibition for
each of the three targets at concentration ranges of between 0.01
and 0.08 ng/mL for the siRNA experiments and between 0.02 to
0.14 ng/mL for the dsRNA experiments. For subsequent
quantitative assessment of transcript abundance, each RNA
sample was diluted to 0.06 ng/mL for the siRNA RT-qPCR
study and 0.11 ng/mL for the dsRNA RT-qPCR study, with 6 mL
of sample used per 25 mL reaction.
Primers and probes. The target sequence under evaluation
in the RT-qPCR study was the B. malayi cathepsin L-like transcript
previously described. Two reference genes were used, a
neuropeptide-encoding gene Bm-flp-14 also previously described,
and Bm-tph-1 (Accession number U80971), a tumor protein
homolog-encoding gene that is a proven reference gene for
qPCR of Brugia development in mosquitoes [33]. TaqMan minor
groove binding (MGB) probes were used in this study to facilitate
the use of shorter gene specific primer-probe sets. All probes and
primers were designed using Primer Express v. 2.0 software
(Applied Biosystems, CA) and synthesized by Applied Biosystems.
The primer and probe sequences used are shown in Table 2.
TaqMan RT-qPCR. 25 mL volume reactions were prepared
in duplicate for each RNA sample, and 20 mL of this reaction
mixture is applied per well on a 96-well plate (using white-well
reaction plates, Eppendorf, NY). Individual components of each
RT-qPCR reaction were as follows: 6 mL prediluted RNA (as
determined by PREXCEL-Q), 6.25 mL 4X One-step Fast Master
Mix with ROX, 1.25 mL qScript One-Step Fast RT, 775 nM each
primer, 150 nM probe, nuclease-free water to 25 mL. Cycling
conditions included an initial cDNA synthesis step of 50uC for
5 min followed by an RT denaturation/Taq activation phase of
95uC for 30 s then 45 cycles of 95uC for 3 s and 58uC for 30 s.
Four point standard curves were created for each target (within the
ng/mL ranges already specified above) by diluting the RNA sample
mixture in each case according to precise, PREXCEL-Q-
determined parameters (eight-fold dilution from highest to lowest
concentration). No-template control reactions substituted
nuclease-free water for RNA, and thermocycling was performed
on an ABI GeneAmp 5700 SDS (Applied Biosystems).
Quantification cycle (Cq) values were obtained at an appropriate
threshold per each target (,0.1 DRn in all cases), and data were
processed using custom Excel files by the efficiency-corrected
(E
DDCq) relative quantification method [32].
Phenotype analysis
After confirmation of Bm-cpl-1 suppression, multiple assays were
performed to describe worm phenotypes. Each phenotypic assay
was performed 14 dpi and at either four or seven d post-injection.
Mosquitoeswerecold-anesthetizedthen the wingsandlegsremoved
and discarded using a dissecting microscope. The head, thorax and
abdomen were partitioned and further dissected to release the
parasites. The following characteristics of dissected parasites were
observed: (1) Parasite location. In order to be successfully transmitted,
these parasites have to actively migrate to the head of the mosquito
and vigorously writhe free of the proboscis. Parasite migration
through the mosquito was recorded and measured according to
escapepoint fromthemosquito body (abdomen,thoraxor head). (2)
Worm motility. A scoring schema of: one (immobile), two (compro-
mised motility, immobile for stretches of time), three (sluggish,
partial movement), four (in motion, some straight segments), or five
(all parts of the worm in constant motion) was used to quantify
parasite movement in a blind fashion by an independent evaluator.
Additional observations of aberrant motility included knotting at
one or both ends, paralysis of caudal region and presence of a
distinct angular kink were also recorded. (3) Parasite growth and
development. Digital images of RNAi and control worms were
captured so that length and diameter could be calculated using NIS
Elements D 2.30 software (Nikon, NY). (4) Parasite viability.T h e
number of parasites that survived to the infectious stage was
recorded so that infection prevalence and mean intensity could be
calculated. (5) Mosquito viability. We documented the number of
mosquitoes that survived through the development of parasites to
the infectious stage because these parasites inflict significant
pathology and decrease mosquito survival.
Microscopy
Nikon Eclipse 50i fluorescence microscope under UV light
(EXFO, ON) equipped with a Hy-Q FITC filter set (Chroma,
VT). Images were captured using a Digital Sight DS-2Mv camera
and NIS Elements D 2.3 software (Nikon, NY).
Statistical analysis
t-tests were used to analyze the effect of RNAi treatment on
gene expression in the RT-qPCR experiments and parasite size,
and ANOVA to analyze the effect of RNAi treatment on worm
motility based on our one through five blind-scoring schema. Chi
square tests were used to analyze the effect of RNAi treatment on
all other worm and mosquito behaviors assayed. In all tests, P
values #0.05 were considered statistically significant.
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